Form 8-K UNITED THERAPEUTICS Corp For: Feb 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
United Therapeutics (UTHR) Tops Q4 EPS Views
February 24, 2015 6:27 AM ESTUnited Therapeutics (NASDAQ: UTHR) reported Q4 adjusted EPS of $3.21, $1.18 better than the analyst estimate of $2.03. Revenue for the quarter came in at $346.4 million versus the consensus estimate of $336.22 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
... More